Relapsing-remitting multiple sclerosis and Infusion site bruising

---

Gender of people who have Relapsing-Remitting Multiple Sclerosis and experienced Infusion Site Bruising *:

• female: 100 %
• male: 0.0 %

Age of people who have Relapsing-Remitting Multiple Sclerosis and experienced Infusion Site Bruising *:

• 0-1: 0.0 %
• 2-9: 0.0 %
• 10-19: 0.0 %
• 20-29: 3.45 %
• 30-39: 13.79 %
• 40-49: 65.52 %
• 50-59: 13.79 %
• 60+: 3.45 %

Common co-existing conditions for these people *:

1. Headache (pain in head): 6 people, 20.00%
2. Weight Decreased: 1 person, 3.33%
3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 3.33%

Common drugs taken by these people *:

1. Paracetamol: 16 people, 53.33%
2. Benadryl: 16 people, 53.33%
3. Gravol: 15 people, 50.00%
4. Tysabri: 5 people, 16.67%
5. Ocrevus: 5 people, 16.67%
6. Vitamin B12: 3 people, 10.00%
7. Tylenol: 3 people, 10.00%
8. Amantadine: 3 people, 10.00%
9. Lemtrada: 2 people, 6.67%
10. Vitamin D: 1 person, 3.33%

Common symptoms for these people *:

1. Headache (pain in head): 23 people, 76.67%
2. Chills (felling of cold): 19 people, 63.33%
3. Rashes (redness): 18 people, 60.00%
4. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 17 people, 56.67%
5. Fever: 17 people, 56.67%
6. Lymphocyte Count Decreased: 16 people, 53.33%
7. Skin Blushing/flushing (a sudden reddening of the face, neck): 16 people, 53.33%
8. Stress And Anxiety: 16 people, 53.33%
9. Pain: 14 people, 46.67%
10. Taste - Impaired: 13 people, 43.33%

Do you take medications and have Infusion site bruising?

- Check whether Infusion site bruising is associated with a drug or a condition